Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder that is characterized by the formation of extracellular amyloid-β (Aβ) plaques. The underlying cause of AD is unknown, however, post-translational modifications (PTMs) of Aβ have been found in AD patients and are thought to play a role in protein aggregation. One such PTM is pyroglutamylation, which can occur at two sites in Aβ, Glu3 and Glu11. This modification of Aβ involves the truncation and charge-neutralization of N-terminal glutamate, causing Aβ to become more hydrophobic and prone to aggregation. The molecular mechanism by which the introduction of pyroglutamate (pE) promotes aggregation has not been determined. To gain a greater understanding of the role that charge neutralization and truncation of the N-terminus plays on Aβ conformational sampling, we used the Drude polarizable force field (FF) to perform molecular dynamics simulations on AβpE3–42 and AβpE11–42 and comparing their properties to previous simulations of Aβ1–42. The Drude polarizable FF allows for a more accurate representation of electrostatic interactions, therefore providing novel insights into the role that charge plays in protein dynamics. Here, we report the parametrization of pE in the Drude polarizable FF and the effect of pyroglutamylation on Aβ. We found that AβpE3–42 and AβpE11–42 alter the permanent and induced dipoles of the peptide. Specifically, we found that AβpE3–42 and AβpE11–42 have modification-specific backbone and sidechain polarization response and perturbed solvation properties that shift the Aβ conformational ensemble.
Keywords: amyloid-β, Alzheimer’s disease, post-translational modifications, pyroglutamate, polarizable molecular dynamics simulations, Drude oscillator
1 |. INTRODUCTION
The amyloid β-peptide (Aβ) is an Alzheimer’s disease (AD)-associated protein that is derived from the amyloid precursor protein (APP) [1], a membrane protein believed to perform many functions [2]. APP is proteolytically cleaved by β-, and γ-secretases to form Aβ [3]. Cleavage can occur at various locations, resulting in Aβ peptides containing 36–43 amino acids [3, 4], with the most common amyloidogenic form of Aβ comprising 42 residues [5]. After Aβ is cleaved, it is released into the extracellular space, where it aggregates into oligomers and ultimately fibrils [6]. This aggregation process, and the mechanism by which oligomers convert into fibrils, is not fully understood, but mutations and post-translational modifications (PTMs) are known to accelerate aggregation [6]. Previous studies indicate that the truncation of the N- and C-termini plays a role in protein aggregation [7, 8, 9].
Several N-terminal truncations have been found in Aβ peptides from AD brains [10, 5, 11]. Here, we will discuss two N-terminal truncations, which leave Glu3 and Glu11 as the new N-termini of the peptides, which can be cyclized by glutaminyl cyclase to form N-terminal pyroglutamate (pE) residues (Figure 1) [12, 13, 14]. Importantly, the pyroglutamylation of N-terminal residues is thought to be a driving force in protein aggregation [15]. Studies have also shown that pyroglutamylated Aβ is prevalent in AD brains [10, 15] and that the most abundant forms of Aβ in AD brains are AβpE3–42 and AβpE11–42 [16, 17]. It is also known that AβpE3–42 is cytotoxic and enhances aggregation [18]. Similarly, AβpE11–42 fibrils have also been found to be more toxic than unmodified fibrils [9]. Although we understand that these truncated, post-translationally modified species of Aβ are toxic, the atomistic details of how pyroglutamylation perturbs Aβ secondary and tertiary structure to modulate aggregation are largely unknown.
FIGURE 1.

Overview of the pyroglutamylation process. The Cα atoms of each residue are labeled with index in, with pyroglutamylation occurring at position i. The peptide bond between residues i-1 and i is hydrolyzed, and the sidechain of residue i subsequently cyclizes to leave the new N-terminus of the polypeptide.
Molecular dynamics (MD) simulations have been widely employed to investigate Aβ dynamics [19, 20]. MD simulations provide atomistic insights into the dynamical behavior of proteins and how they may unfold, sample different conformations, and aggregate. Previous studies on Aβ have principally used nonpolarizable force fields (FFs), providing many useful details of how this peptide misfolds [21, 22, 23]. Gillman et al. used MD simulations to examine pE-containing Aβ pores, finding that AβpE3–42 forms ionic pores in lipid bilayers with higher conductance than pores formed by Aβ1–42 [23]. That study highlighted the importance of investigating how pyroglutamylation changes the electronic properties of the Aβ monomer. However, few studies have simulated pyroglutamylated Aβ, likely because most FFs lack suitable parameters for this species. One limitation of nonpolarizable FFs is that fixed charges cannot redistribute in response to changes in their environment, which may be particularly relevant in the case of pE-containing Aβ. The loss of several charged and polar residues in its N-terminal region yields peptides with different net charges and therefore potentially a greater influence of hydrophobic sequence motifs that are dominated by induced-dipole forces. To advance our understanding of pE-containing Aβ dynamics, we used the Drude polarizable FF [24, 25] to gain insight into how truncation and pyroglutamylation affect Aβ properties.
We previously performed simulations of Aβ mutants to understand the role of electronic polarization and charged amino acids in its dynamics and unfolding of a crucial central region [26]. We found that charge-altering point mutations perturb the secondary structure composition of each Aβ variant and modulate the folding free energies of a core fragment of the peptide as a function of dipole cooperativity among backbone amide groups. Furthermore, we found the interactions between the sidechain and peptide-bond dipole moments result in a hydrophobic C-terminal region (residues 29–42) that may be more aggregation-prone in the Aβ mutants. Here, we expand upon these findings by performing polarizable MD simulations of two pyroglutamylated Aβ42 peptides, AβpE3–42 and AβpE11–42. Though it is known that AβpE3–42 and AβpE11–42 are found in AD brains, the extent to which pyroglutamylation modulates the monomeric Aβ conformational ensemble is unknown. Our principal goal was to understand the role that the N-terminus plays in Aβ misfolding, and how PTMs lead to shifts in secondary and tertiary structure in the earliest events along the aggregation pathway.
2 |. METHODS
2.1 |. Pyroglutamate Parametrization
Parametrization of pyroglutamate was performed using standard methods for the Drude FF, which have been reviewed previously [24]. Quantum mechanical (QM) geometry optimizations and dipole moment calculations were performed with the Gaussian09 program [27] and single-point interaction and configurational energies, and molecular polarizability calculations were computed with Psi4 [28]. The MP2/6–31+G* model chemistry was used for all QM geometry optimizations, and the RIMP2/aug-cc-pVQZ model chemistry was applied for molecular polarizability, interaction energy, and single-point energy calculations, for consistency with other elements of the Drude FF [24, 25].
All molecular mechanics (MM) calculations were performed using the CHARMM program [29] with the Drude-2019 polarizable FF [25]. The initial set of coordinates for the pyroglutamate dipeptide (comprising pyroglutamate with an N-methylacetamide capping group on the C-terminus) was built using the CHARMM internal coordinate builder. After each step in the parametrization process, energy minimization was performed to compare the molecular geometry against that of the QM-optimized structure. Initial bonded and nonbonded parameter assignment was done by analogy to chemically similar groups already present in the Drude FF.
Following an initial geometry comparison, the electrostatic parameters (charges, atomic polarizabilities, and Thole screening factors) were optimized. The parameters associated with the C-terminal amide group of the pyroglutamate dipeptide were kept fixed for compatibility with the existing Drude-2019 FF. Initial parameters for other atoms and bonds were taken from the Gln and backbone parameters from Drude-2019 FF and refined using methods described in Lin et al. [25]. A Monte Carlo/simulated annealing (MC/SA) algorithm [30] was used to optimize the atomic polarizabilities and Thole screening parameters, as well as dihedral force constants. The error function was defined as the root-mean-square error (RMSE) between the QM and MM values for the quantities being fit (see below). The initial temperature was set to 500 K and was periodically scaled by a factor of 0.75 until the RMSE converged. New parameters were accepted if the RMSE decreased or if, in the case of an increase, the Metropolis criterion was satisfied at the current temperature. Convergence was defined as the RMSE difference being less than 0.001 between two consecutive MC/SA cycles.
The target data for fitting electrostatic parameters were the QM total dipole moment, |μ|, and its μx, μy, and μz components, and the total molecular polarizability (αiso) and its diagonal αXX, αYY, and αZZ components. The Drude dipole moment and molecular polarizabilities were obtained by reading the QM optimized geometry, adding Drude oscillators and lone pairs, and relaxing the Drude oscillator positions via steepest-descent and adopted-basis Newton-Raphson (ABNR) minimization, as described by Lin et al. [25]. The gas-phase QM molecular polarizability overestimates the electric field response in solution [24, 25], so the calculated values were scaled by 0.85 for use as target data in the fitting protocol.
A key feature of the parametrization of the Drude FF is the explicit consideration of individual interactions of chemical functional groups with water, in terms of both geometry and interaction energy. These interaction energy calculations are used to tune interactions in a self-consistent manner throughout the entire FF and are used to validate and, if necessary, further optimize the electrostatic parameters derived by targeting QM dipole moment and molecular polarizability values. We assessed the interactions of water molecules placed in-plane and out-of-plane around the lactam ring of the pyroglutamate dipeptide (Figure 2). The distances between the water molecules and the pyroglutamate dipeptide functional groups were optimized via rigid QM scans in Gaussian09 [27] using the MP2/6–31+G* model chemistry, and interaction energies were obtained in Psi4 [28] using the RIMP2/aug-cc-pVQZ model chemistry, with counterpoise correction for basis-set superposition error [31, 32].
FIGURE 2.

Geometries for all water interactions with the pyroglutamate dipeptide. Each calculation was performed on a dimeric system (one pyroglutamate dipeptide and one water molecule). The composition of the image represents all the interactions that were considered as a part of the parameter validation and optimization.
One torsion in the pyroglutamate dipeptide was not previously parametrized in the Drude FF, namely N-Cδ-Cγ-Cβ. Starting from the QM optimized geometry, configurations were generated that set this torsion to values from −40° to 40° in intervals of 10°. The geometries were optimized with this torsion frozen and all other degrees of freedom allowed to relax. Drude dihedral parameter refinement was performed with the MC/SA algorithm described above.
2.2 |. Molecular Dynamics Simulations
System Setup.
The starting coordinates for the full-length Aβ42 were obtained from the denatured WT structures produced in the simulations described in our previous work [26]. The full-length simulations, to which properties are compared here, were published in that study. AβpE3–42 and AβpE11–42 were generated by deleting residues 1–2 and 1–10, respectively. The new N-terminal Glu was patched in CHARMM to produce the pyroglutamylated N-terminus to make AβpE3–42 and AβpE11–42 using the CHARMM internal coordinate builder [29]. The C-termini of all peptides were modeled in their ionized forms. As with the full-length peptide, we simulated AβpE3–42 and AβpE11–42 in triplicate for 1 μs each, totaling 3 μs for each Aβ42 variant. All systems were initially prepared using the additive CHARMM36m (C36m) protein FF [33], then later converted to the Drude-2019 polarizable FF [24, 25] with the addition of the pyroglutamate parameters described above.
Each protein was solvated in a 72-Å cubic box of CHARMM-modified TIP3P [34, 35, 36] water and ~150 mM KCl, including K+ counterions. The systems were energy-minimized in CHARMM [29] using 1000 steps of steepest descent minimization and 1000 steps of ABNR minimization.
Equilibration and Production Simulations.
Following minimization, equilibration was carried out in NAMD [37] for 1 ns. During equilibration, position restraints were applied to all non-hydrogen protein atoms with a force constant of 5 kcal mol−1 Å−2. An NPT ensemble was maintained by regulating temperature at 310 K with the Langevin thermostat method [38, 39] using a friction coefficient, γ, of 5 ps−1. The pressure was set to 1 atm using the Langevin piston method [39] (oscillation period = 200 fs; decay time = 100 fs). Periodic boundary conditions were applied in all directions, and the short-range van der Waals forces were smoothly switched to zero over 10 – 12 Å. The particle mesh Ewald (PME) method [40, 41] was used to calculate the electrostatic interactions with a real-space cutoff of 12 Å and grid spacing of approximately 1 Å. Bonds to hydrogen atoms were held rigid using the SHAKE algorithm [42], allowing an integration time step of 2 fs in C36m simulations.
Following C36m equilibration, the systems were converted to the Drude polarizable model using CHARMM by adding Drude oscillators and lone pairs to the equilibrated coordinates. Additionally, the TIP3P water molecules were converted to the polarizable SWM4-NDP model [43]. Drude oscillators were relaxed using 2000 steps of steepest descent and 1000 steps of ABNR energy minimization. The Drude systems were equilibrated in NAMD using extended Lagrangian integration, implemented as Langevin dynamics [44, 45]. An NPT ensemble was maintained, and the temperature and pressure were set to 310 K and 1 atm, respectively, unless otherwise specified. Bonds involving hydrogen atoms were constrained using the SHAKE algorithm as described above.
The temperature was regulated using a dual Langevin thermostat, coupling all real atoms at 310 K (γ = 5 ps−1) and the Drude oscillators to a low-temperature relative thermostat at 1 K (γ = 20 ps−1). The short-range Lennard-Jones potential was switched to zero from 10 – 12 Å and electrostatic interactions were calculated with PME, using the same settings as the additive simulations. The same harmonic position restraints and bond constraints were applied as the additive simulations, but the integration time step was set to 1 fs because of the high-frequency nature of the Drude-atom bonds. To avoid polarization catastrophe, a “hard wall” constraint [46] was applied to allow a maximum Drude-atom bond length of 0.2 Å. Equilibration of polarizable systems was carried out for 1 ns. Following equilibration, the restraints were removed and the production simulations were performed in OpenMM [47, 48]. The NPT ensemble was maintained using the same thermostat settings as equilibration, except that pressure was regulated at 1 atm using a Monte Carlo barostat with box scaling attempted every 25 integration steps.
2.3 |. Analysis
Assessment of Convergence.
Analysis of the simulations was performed on the last 500 ns of each replicate, totaling 1.5 μs of analyzed time for each system. Because we built the pyroglutamylated Aβ systems from the starting structures described previously [26], the first 500 ns of each trajectory was characterized by considerable structural rearrangement. After 500 ns, the systems appeared to reach a point of convergence based on the root-mean-square deviation (RMSD) and radius of gyration (Rg) (Supporting Information, Figures S1 and S2).
Dipole Moment Analysis.
Dipole moments for peptide bonds, sidechains, and water molecules were computed using the COOR DIPOLE command in CHARMM, defining the center of mass of each selection of atoms as the origin for the dipole moment to remove any dependence on absolute coordinates for charged sidechains. Each peptide bond was defined as in previous work [49], including atoms from two consecutive amino acids to define a net-neutral group. Water dipole moments were computed for any water molecule in the first solvation shell, defined as having an Ow-protein heavy atom distance ≤ 3.5 Å. Distance dependence was subsequently analyzed by binning these water molecules across the range of distances observed (approximately 2 Å to 3.5 Å, using a bin size of 0.1 Å). To assess the impact of each amino acid on water dipole moments, we considered only water molecules within the first solvation shell of the residue of interest and not in the first solvation shell around any other protein residue. By doing so, we ascribed the properties of the water molecules to a single amino acid.
Structural Analysis.
Solvent-accessible surface area (SASA) of each residue was computed using the CORREL feature of CHARMM. Only real atoms were considered in the analysis (that is, Drude oscillators and lone pairs were not included). The molecular surface was computed for the entire peptide using a probe radius of 1.4 Å. Clustering of simulation snapshots was performed using the ART-2’ RMSD-based clustering method [50, 51, 52] in CHARMM with a 3-Å maximum cluster radius as described in our previous work [26]. This method uses a self-organizing neural net to define characteristic clusters of time series data such that individual data points are grouped by a maximum radius from a cluster center. Thus, by using RMSD, we clustered the simulation ensemble by structural similarity. Tertiary structure was characterized by contact maps generated using the “gmx mdmat” program in GROMACS [53].
3 |. RESULTS AND DISCUSSION
3.1 |. Pyroglutamate Parametrization
To verify that the pyroglutamate topology produced good agreement with the QM electrostatic properties, the total dipole moment and molecular polarizability, and their spatial components, were calculated as described in Methods. The dipole moments and molecular polarizabilities are listed in Tables 1 and 2, respectively. The QM molecular polarizabilities in Table 2 are scaled by a factor of 0.85 for reasons described previously [24]. The optimized pyroglutamate dipeptide parameters yielded good agreement with the QM values for both the dipole moments (Table 1) and molecular polarizabilities (Table 2). We note that the errors are largest along the x-component of each of these quantities, which corresponds to the longest principal axis of the dipeptide. As only a portion of this model compound was subject to elecrostatic fitting (see Methods), we accepted a small amount of error for the sake of compatibility with the remaining elements of the Drude-2019 protein FF.
TABLE 1.
Total dipole moments and components (in D) of the pyroglutamate dipeptide.
| QM (MP2/6–31+G*) | Drude | |
|---|---|---|
| μ x | 7.05 | 6.21 |
| μ y | −0.69 | −1.68 |
| μ z | 1.24 | 0.84 |
| |μ| | 7.19 | 6.49 |
TABLE 2.
Components of the unscaled and scaled molecular polarizability tensors and isotropic polarizabilities (Å3) of the pyroglutamate dipeptide.
| QM (RIMP2/aug-cc-pVQZ) | QM × 0.85 | Drude | |
|---|---|---|---|
| α xx | 15.46 | 13.14 | 10.74 |
| α yy | 13.61 | 11.57 | 11.85 |
| α zz | 11.47 | 9.75 | 9.18 |
| α iso | 13.52 | 11.49 | 10.59 |
Following confirmation of the dipole moments and molecular polarizabilities, the interactions of the pyroglutamate dipeptide with water (Figure 2) were calculated to further evaluate the parameters. The new pyroglutamate water interactions were in good agreement with the target QM data, in terms of both locations of energy minima and the interaction energies themselves (Table 3). The alkyl group-water interactions (HB1_180 and HG1_180) using the Drude FF did not adopt a stable minimum within 2.5 Å and thus the distance between the water molecules and pyroglutamate dipeptide was set to be 2.50 Å for the interaction energy calculation. This property is typical of water interactions with aliphatic groups in both the CHARMM and Drude FFs [24].
TABLE 3.
Water interaction energies (Eint, kcal mol−1) and minimum-energy distances (rmin, Å). In cases of rmin = 2.50 Å in Drude calculations, no energy minimum was identified within that distance so Eint was evaluated at 2.50 Å.
| QM | Drude | Difference | ||||
|---|---|---|---|---|---|---|
| rmin | Eint | rmin | Eint | rmin | Eint | |
| 1. OE1_180 | 1.98 | −5.34 | 1.94 | −6.10 | −0.04 | −0.76 |
| 2. OE1_out | 2.07 | −5.03 | 1.94 | −6.16 | −0.13 | −1.13 |
| 3. OE1_CG | 1.96 | −6.41 | 1.91 | −6.77 | −0.05 | −0.36 |
| 4. OE1_N | 1.93 | −6.49 | 1.89 | −6.45 | −0.04 | 0.04 |
| 5. HN_180 | 1.97 | −2.65 | 1.99 | −3.00 | 0.02 | −0.35 |
| 6. HG1_180 | 2.31 | −1.24 | 2.50 | −1.18 | 0.19 | 0.06 |
| 7. HB1_180 | 2.26 | −2.50 | 2.50 | −2.48 | 0.24 | 0.02 |
Once the dipole moments, molecular polarizabilities, and pyroglutamate water interactions were evaluated against the QM data, we analyzed the configurational energies as a function of the N-Cδ-Cγ-Cβ dihedral to ensure they were also in agreement with the QM data. Since the backbone parameters of most of the pyroglutamate were not adjusted as they are a core part of the FF, the only dihedral that needed to be parametrized was the angle encompassing N-Cδ-Cγ-Cβ (Supporting Information, Figure S3). The optimized Drude parameters for the N-Cδ-Cγ-Cβ dihedral produced good agreement with the QM energies (Figure 3). As such, the evaluation of all of the newly developed parameters indicated that they were sufficiently accurate for use in MD simulations. The CHARMM-formatted pyroglutamate patch and the associated parameters for it are provided in the Supporting Information.
FIGURE 3.

One-dimensional potential energy surfaces as a function of the pyroglutamate dipeptide N-Cδ-Cγ-Cβ torsion. QM potential energies are computed using the RIMP2/aug-cc-pVQZ model chemistry following MP2/6–31+G* optimization.
3.2 |. AβpE3–42 and AβpE11–42 Simulations
The effects of pyroglutamylation on the conformational ensemble of monomeric Aβ are not fully understood. Here, we simulated the truncated AβpE3–42 and AβpE11–42 forms of Aβ to gain a greater understanding of the role that charge alteration plays on secondary and tertiary structure, and the extent to which the truncation and modification alter the transition between helical and disordered states. Studying these truncations provides us with insight into the role that the polar N-terminal residues (particularly residues 1–10) play in Aβ misfolding. In addition, understanding the tertiary structure and contacts that are formed yields insight into how pyroglutamylation shifts the conformations in a way that impacts the aggregation pathway.
3.2.1 |. Pyroglutamylation Shifts α-Helical and β-Strand Propensity of Aβ
Given that interconversion between α-helical and β-strand structures is believed to be central to the aggregation of Aβ [54], we began by comparing the α-helical and β-strand content of of AβpE3–42 and AβpE11–42. We recently reported the secondary structural features of Aβ42 [26], which serve as a comparison for the present study. We did not observe any β-sheet content in either AβpE3–42 or AβpE11–42. Persistent β-sheets are more likely in higher-order Aβ oligomers and fibrils, though we note the appearance of some short β-strands in our previous simulations of full-length Aβ42 [26]. The absence of β-strands here suggests that neutralization of the N-terminus and removal of several residues may impact the stability of these structures within Aβ42.
We found that the AβpE3–42 had increased α-helical content throughout the peptide relative to the full-length peptide, although none of these structures persisted for long periods of time (Supporting Information, Figure S4). This observation suggests that the pyroglutamylation at Glu3 results in a hydrogen bonding network that favors several short (4–5 residue) α-helical turns, as compared to the unmodified Aβ42, which was characterized by a single, slightly longer central α-helix. AβpE11–42 was similar to Aβ42 in overall α-helical content, as well as adopting α-helical structures involving the same residues. Thus, pyroglutamylation at Glu11 may not shift the secondary structure content of Aβ42 as much as the modification at Glu3. This result is somewhat surprising given that the AβpE3–42 peptide has fewer residues deleted from it as a consequence of the modification, leading to an expectation that its properties would be similar to those of the unmodified Aβ42. Our results suggest that deletion of the first ten residues, which are primarily charged and polar, does not substantially alter the secondary structure preferences of Aβ42.
Previous work suggests that the transient formation of α-helical intermediates may play a role in Aβ oligomer formation [55]. Our observations here suggest that AβpE3–42 may facilitate adoption of secondary structure elements that are “on-pathway” for Aβ42 aggregation, whereas AβpE11–42 may adopt an ensemble of structures that is similar to the full-length Aβ42 and therefore it may not differ in its propensity for aggregation, at least from the standpoint of secondary structure evolution.
We note that our results differ from those of a recent study by Nath et al. [56], who found that pyroglutamylation increased β-sheet in the AβpE3–42 monomer relative to Aβ42; they did not examine AβpE11–42 in their work. Their study applied replica-exchange MD simulations with the CHARMM36m nonpolarizable force field [33], so some differences may be due to the force fields applied. Nath et al. found an overall increase in β-sheet content in the AβpE3–42 monomer relative to Aβ42, with localized increase in α-helicity among residues 24–28. Here, we found no increase in β-strand (or sheet) content and increased helicity in residues 24–28. One aspect of the Drude polarizable force field that is important in this context is the explicit modeling of cooperative dipole induction. This effect is the reason for inadequate helix-coil equilibrium in the model (AAQAA)3 peptide with CHARMM36 but proper temperature dependence with the Drude force field [57]. We have also noted the importance of dipole cooperativity in Aβ in our previous work on the unfolding of the central region of the peptide [26].
Nath et al. further noted “significantly stronger” Glu22-Lys28 and Arg5-Glu22 salt bridges in AβpE3–42 that contribute to a shifted conformational ensemble. We note that nonpolarizable force fields tend to overstate the strength of these interactions [58], which may be particularly important in amyloidogenic proteins with unusual microenvironments in which these salt bridges occur, as their properties may strongly depend on their surroundings [26].
3.2.2 |. AβpE3–42 and AβpE11–42 Adopt Distinct Tertiary Structures
The contributions of secondary structure (disorder) and tertiary structure (compactness and accessibility of aggregation-prone motifs) govern the earliest events of oligomer nucleation [55, 59]. Thus, characterizing the tertiary structures of the modified systems is crucial to our overall understanding of how truncation and modification lead to a more aggregation-prone peptide.
The simulation ensembles for both AβpE3–42 and AβpE11–42 were heterogeneous, as characterized by a large number of clusters from our RMSD-based clustering approach. For AβpE3–42, 477 distinct clusters were generated, although only 140 of these contained more than one snapshot and only 7 clusters contained more than 2% of the ensemble. The most-occupied cluster represented 16.3% of the overall ensemble. Similarly, for AβpE11–42, 206 clusters were produced, of which 115 contained more than one snapshot and 10 contained more than 2% of the ensemble. The most-occupied cluster for this species represented 5.7% of the ensemble. Figure 4 shows the most representative structures from the top cluster of RMSD-based clustering for both AβpE3–42 and AβpE11–42. Notably, the pE residue behaved differently in these species. In AβpE3–42, the pE3 residue was buried deeply in the core of the collapsed peptide structure, surrounded by other hydrophobic residues (Figure 4A). In AβpE11–42, the pE11 residue was exposed to solvent and the overall architecture of the peptide was more expanded than that of AβpE3–42 (Figure 4B).
FIGURE 4.

Representative structures of AβpE3–42 and AβpE11–42 highlighting the dominant tertiary interactions seen in the Cα-Cα distance matrices. Residues colored in blue are those with ≥25% increase in sidechain SASA and those in red are residues with ≥25% reduction in sidechain SASA, relative to Aβ42. The green residue in both panels is pyroglutamate.
To quantitatively analyze tertiary structure, we calculated the pairwise distances between every Cα atom to describe the residue-residue contacts (Figure 5) and the per-residue solvent-accessible surface area (SASA). We calculated the change in SASA relative to Aβ (Figure 6). Both the AβpE3–42 and AβpE11–42 peptides had long-range contacts between N-terminal residues and those of the hydrophobic C-terminal region. The hydrophobic C-terminal residues of both AβpE3–42 and AβpE11–42 interacted with the central hydrophobic cluster (CHC, residues 17–21), likely driven by the residues attempting to shield themselves from the solvent and polar residues. None of these interactions were present in Aβ42 [26]. Correspondingly, the C-terminal region of both AβpE3–42 and AβpE11–42 had similar patterns of solvent accessibility. Residues Gly33-Gly38 were more solvent-exposed than in Aβ42, whereas Val39-Ala42 were less solvent-exposed. This change in solvent accessibility occurred because the pyroglutamate interacted with residues Val40-Ala42 (Figures 4 and 5), thus shifting the Gly33-Gly38 sequence into solvent. These observations highlight that the pyroglutamylation of Aβ results in shifts in the tertiary contacts that lead to the hydrophobic C-terminal region and CHC making closer contacts in the modified systems.
FIGURE 5.

Cα-Cα distance matrices of (A) AβpE3–42 and (B) AβpE11–42. All frames from the last 500 ns of each of the three replicate simulations for each system were pooled for this analysis.
FIGURE 6.

Change in solvent-accessible surface area (SASA), expressed as a percentage difference relative to the full-length Aβ42 values.
In AβpE3–42, residues Phe4, Arg5, Asp7, Ser8 were less solvent-exposed relative to the full-length peptide because of the interactions that occurred between the pyroglutamate and the hydrophobic C-terminal residues. Thus, interactions among hydrophobic groups (including the N-terminal modified residue) can therefore drive the partial burial of polar and charged residues such as Arg5, Asp7, and Ser8. The burial of the N-terminal pE3 residue in AβpE3–42 caused a major reorganization of intrapeptide contacts that included the formation of an Arg5-Ala42 salt bridge (Figure 4A) that may also help stabilize this architecture. In contrast, other N-terminal residues that did not interact with the C-terminus (His6, Gly9-Val12) had increased per-residue SASA (Figure 6A). Several residues in the C-terminal hydrophobic region had increased SASA relative to Aβ42, notably Leu34 and Met35.
In AβpE11–42, His13 was less solvent-exposed than in the full-length Aβ42, but the surrounding residues more solvent-exposed, most notably pE11, Val12, and Gln15 (Figures 4 and 6B). The increase in solvent accessibility of Gln15 was coupled to a burial of Ala42, with which it interacted closely (Figures 4B and 5B). The sidechain of Ala42 then packed closely with that of Leu34, defining the core of the dominant AβpE11–42 morphology. As a result, several key residues in the CHC (Leu17, Val18, and Phe20) and in the C-terminal hydrophobic region (notably Leu34) were more solvent-exposed than Aβ42 (Figure 6B). Taken together, the SASA results indicate that the hydrophobic residues of both AβpE3–42 and AβpE11–42 are more solvent-exposed, potentially resulting in aggregation-prone regions to interact more readily with solvent.
3.2.3 |. Perturbation of Peptide-Bond and Sidechain Dipole Moments
Adoption of secondary structure in polypeptide chains derives from hydrogen bonding, which is a directional alignment of complementary dipoles. Tertiary structure formation is driven by packing of sidechains that subsequently define microenvironments in the folded structure. Therefore, there should be a direct connection between the structure of a polypeptide and its electrostatic properties. Alignment of peptide-bond dipoles leads to cooperative induction that ultimately gives rise to the helix macrodipole [49, 57, 60, 61], and different values of peptide-bond dipole moments are associated with specific polypeptide geometries [57]. Thus, changes in dipole moments reflect changes in structure, particularly in the case of helix-coil equilibrium, as polarization of peptide bonds will vary in response to changes in solvent exposure or the hydrogen bonding network. To relate secondary structure preferences with the electronic structure of the polypeptide backbone, we calculated the peptide-bond dipole moments of each amide group linking consecutive residues (Supporting Information, Table S1 Peptide-bond dipole moments of the Aβ42, AβpE3–42, and AβpE11–42 systems.table.1).
The per-residue peptide-bond dipole moments of the pyroglutamylated peptides were compared against the equivalent residues of Aβ42. We found that peptide bonds within the CHC of both AβpE3–42 and AβpE11–42 were depolarized relative to the full-length Aβ42. The decrease in peptide-bond dipole moments among CHC residues suggests that tertiary structure interactions may cause depolarization. From the analysis of inter-residue contacts (Figure 5), residues in the hydrophobic C-terminal region tended to interact with residues in the CHC. The resulting hydrophobic microenvironment is likely the reason for depolarized backbone amide groups, which were subsequently more shielded from solvent and thus accommodated their new surruondings by decreasing their dipole moments. This depolarization of the peptide bonds also suggests that pyroglutamylation weakens the hydrogen bonding network of Aβ, which leads to the depolarization of the aggregation-prone CHC. Given that this outcome is a due to multiple factors, including backbone geometry and surrounding microenvironment due to sidechains and water molecules, additional systematic studies of model polypeptide sequences in different geometries will be necessary to rigorously test this hypothesis.
Within the hydrophobic C-terminal region of AβpE3–42, peptide bonds were generally depolarized relative to Aβ42, with the exception of the Val36-Gly37 and Ile41-Ala42 peptide bonds. The peptide bonds spanning Gly29-Met35 and Gly38-Val40 otherwise exhibited pronounced depolarization (Figure 7). In contrast, the C-terminal region of AβpE11–42 was more polarized than Aβ42, particularly among residues Val39-Ala42. This difference in dipole response was somewhat unexpected, as the levels of solvent exposure among these residues were similar between the two pyroglutamylated peptides (Figure 6). Therefore, the differences in polarization among peptide bonds reflect differences in tertiary structure and thus distinct microenvironments. As a consequence, AβpE3–42 and AβpE11–42 may undergo different unfolding pathways. Indeed, the increased polarization among the peptide bonds within Gly38-Ala42 in AβpE11–42 suggests that these functional groups may be more favorably solvated, contributing to disorder.
FIGURE 7.

Differences in peptide-bond dipole moments relative to Aβ42.
Both pyroglutamylated peptides exhibited strongly depolarized peptide bonds within the CHC. Depolarization is expected to be correlated with solvent occlusion, as the decrease in dipole moment would make these functional groups less favorably solvated. Only modest differences in SASA were observed for these residues relative to Aβ42, suggesting interactions with water are similar among all three peptides. Therefore, the depolarization should be attributable to intrapeptide effects. In AβpE3–42, the CHC residues had the largest tendency to form α-helical structures, so it may be expected that the peptide-bond dipole moments would be enhanced in these residues [57]. The fact that they did not suggests that the α-helical structures were somewhat weak as a function of the tertiary structure, a fact that is reflected in the preference for disordered, coil structures in this region of the peptide. The consistently depolarized nature of these amide groups strongly indicates that as a function of pyroglutamylation, these peptide bonds prefer to be shielded from water, which may be an additional driving force for their aggregation.
We also assessed convergence across replicate simulations by comparing the average value of peptide-bond dipole moments. By doing so, we complemented our structural assessment of convergence over time by comparing peptide-bond dipole moments as an ensemble property. Overall, the average values obtained across replicates were consistent, with standard deviations calculated from the three mean values for each peptide bond on the order of approximately 0.1 D, with very few exceptions (Supporting Information, Figure S5).
We then calculated the sidechain dipole moments for each residue and compared them to the Aβ42. For this analysis, we omitted direct comparisons between glutamate and pyroglutamate, as well as glycine, which has no sidechain. Changes in sidechain dipole moments, expressed as percentages relative to Aβ42, are shown in Figure 8. We found that the sidechain dipole moments largely followed the SASA changes (that is, residues with increased SASA resulted in larger dipole moments, and vice-versa). This parallel pattern suggests that shifts in tertiary contacts and interactions with water result in corresponding shifts in the electric field around each residue. One particularly obvious example of this phenomenon was Phe4 in AβpE3–42, which packed against the N-terminal pyroglutamate (Figure 4); its sidechain dipole moment was strongly depolarized as a result (Figure 8). This outcome highlights that the neutralization and increased hydrophobicity of AβpE3–42 and AβpE11–42 result in changes in important microenvironments, which subsequently manifest as shifts in sidechain dipole moments.
FIGURE 8.

Change in sidechain dipole moments, expressed as a percentage relative to the values of the full-length Aβ42 peptide. All glycine and modified residues are shown as 0% change to indicate that the comparison was not made for these residues.
3.2.4 |. Pyroglutamylation Perturbs the Solvation Shell Around Aβ42
The solubility of any protein or polypeptide depends, in part, on the interactions among surface-exposed amino acids and water. To understand the impact that pyroglutamylation has on the solvation shell around each Aβ peptide, we calculated the molecular dipole moments of all water molecules in the first solvation shell (heavy atom-Ow distance ≤ 3.5 Å). We further decomposed these water molecules into those that were within the first solvation shell of each residue in the peptide but not in the first solvation shell of any other residue. Results of this analysis are shown in Figure 9.
FIGURE 9.

Perturbations to water dipole moments in the first solvation shell around each peptide. (A) Average molecular dipole moments of water molecules as a function of distance away from the nearest peptide heavy atom. (B) Average molecular dipole moments of water molecules exclusively in the first solvation shell around each residue. (C) The difference in water dipole moments around each residue relative to that of the full-length Aβ42. The legend shown between panels (A) and (B) applies to both panels. Error bars indicate the root-mean-square deviation of the pooled data sets. The horizontal, light blue line in panels (A) and (B) corresponds to the average bulk dipole moment of the SWM4-NDP water model (2.47 D).
A previous study by Ngo et al. examined the solvation properties of a model α-helix and β-hairpin structures [62]. They found that water molecules closest to the peptide surfaces were depolarized relative to bulk water (for the SWM4-NDP model, the bulk dipole moment is 2.47 ± 0.16 D [43]). The effects were greater for the α-helix, which may be a function of its specific sequence. We observed a similar behavior here in the case of each of the Aβ peptides. First-shell water dipole moments around Aβ42 averaged 2.43 ± 0.16 D, and for both AβpE3–42 and AβpE11–42, this value was 2.42 ± 0.16 D. Thus, all Aβ variants examined here behaved similarly and the observed depolarization effect was slightly smaller than what was observed by Ngo et al. By decomposing these water molecule dipole moments as a function of distance away from the nearest peptide heavy atom, we observed a strong polarization effect (|Δμwat| ≈ 0.3 D) within 2.5 Å (Figure 9A). Aβ42 had the most polarized water molecules, likely as a result have having a greater number of charged residues relative to the pyroglutamylated forms, though this effect was small (Figure 9A). Water molecules from 2.5 – 3.5 Å away from the peptide surfaces tended to have dipole moments at, or slightly below, that of bulk SWM4-NDP.
We further sought to decompose this behavior on a per-residue level, by calculating the water dipole moments for molecules in the first solvation shell of each amino-acid residue that were not also within the first solvation shell of any other residue. Doing so will ignore residues that interact with multiple residues simultaneously but allow us to connect polarization effects among water molecules with solvent accessibility analysis described above. Results of this analysis are shown in Figure 9B. Among all the Aβ peptide variants studied here, the only residues for which observed water dipole moments were greater than the bulk water value are for acidic residues (Glu3, Glu11, Glu22, and Asp23) and the C-terminal Ala42, which is exerting this effect through its anionic C-terminal carboxylate group in Aβ42 and AβpE11–42. In AβpE3–42, Ala42 interacted strongly with Arg5 via a salt bridge (Figure 4), screening the charge on the carboxylate and leading to a slight depolarization of water molecules around the methyl sidechain. For all other residues, the water molecules were depolarized relative to bulk. Therefore, the observed polarization effects among the closest water molecules was likely due to simultaneous interactions of water with multiple Aβ residues and are difficult to describe in per-residue terms. Nevertheless, it is interesting that the closest water molecules within the first solvation shell are strongly polarized, but overall the first solvation shell is depolarized relative to bulk water.
Finally, we computed the difference in water dipole moments as a function of interaction with each residue (Figure 9C). The data shown in Figure 9C were obtained by taking the difference between the per-residue data in Figure 9B. While the magnitudes of these differences are small, they provide important context for the relationship with perturbations to SASA described above and shown in Figure 6. Given the general tendency of hydrophobic residues in the region comprising residues 30–42 of the AβpE peptides to become more solvent exposed (Figure 6), most of their surrounding water molecules tended to depolarize in response (Figure 9B,C). Water molecules around the Glu3 and Glu11 residues were also substantially depolarized due to the fact that pyroglutamylation renders these residues uncharged and far more hydrophobic. In addition, water molecules surrounding the CHC were generally among the most strongly depolarized, though this region of Aβ was not strongly impacted by pyroglutamylation. Additional investigations on solvation properties should be conducted to probe this effect further. Nevertheless, this analysis of the solvation shell of Aβ and its pyroglutamylated forms indicates that release of these water molecules into bulk, relaxing them back to their equilibrium dipole moments, may contribute to the aggregation process. Therefore, the perturbations induced by pyroglutamylation may be an additional contributing factor in describing this process.
4 |. CONCLUSIONS
Here, we have described the development of pyroglutamate parameters compatible with the Drude-2019 FF. The newly developed parameters were compared against QM data and were of comparable quality to previously developed parameters of other molecules [63, 25]. These parameters were subsequently used to perform simulations of pyroglutamylated Aβ.
Our results are also the first study of monomeric AβpE3–42 and AβpE11–42 carried out with a polarizable FF. We found that the pyroglutamylation at positions 3 and 11 results shifted inter-residue contacts and conformations that give rise to changes in dipole-dipole interactions. Specifically, AβpE3–42 results in shifts in the secondary structure that correspond to changes in peptide-bond dipole moment and changes in SASA. Furthermore, AβpE3–42 and AβpE11–42 adopt similar tertiary contacts that cause the hydrophobic C-terminus (residues 39–42) to interact closely with pyroglutamate at positions 3 and 11. This shift in tertiary contacts leaves much of the hydrophobic C-terminal region more solvent-exposed.
This shift in tertiary structure suggests that the modification of the N-terminus may cause Aβ to have residues that are normally solvent-occluded to become exposed, causing the peptide to become more prone to aggregating. We also note that the change in tertiary structure results in similar changes in sidechain dipole moments, highlighting that AβpE3–42 and AβpE11–42 may adopt unique microenvironments that give rise to different conformational ensembles that are sensitive to induced electronic polarization effects. Overall, we found that changes in secondary and tertiary structure are largely driven by perturbations to peptide-bond and sidechain dipole moments. These data suggest that the polar N-terminal residues 1–10 may serve to modulate the interactions among the hydrophobic regions of Aβ that lead to aggregation, and their removal via pyroglutamylation may enhance aggregation. Further, the impact of pyroglutamylation extends to mutual polarization effects between the Aβ peptides and the first solvation shell, perhaps exposing a new contributor to the forces driving aggregation of these species.
Supplementary Material
Acknowledgments
The authors thank Dr. Marcelo D. Polêto for help and advice in performing analysis and for critical review of the manuscript. The authors also thank Virginia Tech Advanced Research Computing for computing time and resources. This work was supported by the National Institutes of Health (grant R35GM133754, to J.A.L.) and the USDA-NIFA (project VA-160092).
Funding information
National Institutes of Health, National Institute of General Medical Sciences, Grant/Award Number: R35GM133754; United States Department of Agriculture, National Institute of Food and Agriculture, Grant/Award Number: VA-160092
Abbreviations:
- AD
Alzheimer’s disease
- PTM
post-translational modification
- Aβ
amyloid-β
- pE
pyroglutamate
- FF
force field
- APP
amyloid precursor protein
- QM
quantum mechanics
- MM
molecular mechanics
- MC/SA
Monte Carlo/simulated annealing
- RMSD
root-mean-square deviation
- RMSE
root-mean-square error
- ABNR
adopted-basis Newton-Raphson
- SASA
solvent-accessible surface area
Footnotes
Conflict of Interest
The authors declare no conflict of interest.
Data Availability Statement
The input files (coordinates, topologies, and associated force field parameter files) are available via the Open Science Framework at https://osf.io/mqcfd/. Examples of CHARMM, NAMD, and OpenMM input scripts are available at https://github.com/jalemkul/mimb2020.
references
- [1].Weggen S, Beher D. Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer’s disease. Alzheimer’s Research and Therapy 2012;4:9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334542/pdf/alzrt107.pdf http://alzres.biomedcentral.com/articles/10.1186/alzrt107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Turner PR, O’Connor K, Tate WP, Abraham WC. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Progress in Neurobiology 2003;70(1):1–32. [DOI] [PubMed] [Google Scholar]
- [3].Sisodia SS. β-Amyloid precursor protein cleavage by a membrane-bound protease. Proceedings of the National Academy of Sciences of the United States of America 1992;89(13). [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Nunan J, Small DH. Regulation of APP cleavage by α-, β- and γ-secretases. FEBS Letters 2000;483:6–10. [DOI] [PubMed] [Google Scholar]
- [5].Mori H, Takio K, Ogawara M, Selkoe DJ. Mass spectrometry of purified amyloid β protein in Alzheimer’s disease. The Journal of Biological Chemistry 1992. 8;267(24):17082–6. [PubMed] [Google Scholar]
- [6].Marksteiner J, Humpel C. β-amyloid expression, release and extracellular deposition in aged rat brain slices. Molecular Psychiatry 2008. 10;13:939–952. http://www.nature.com/articles/4002072. [DOI] [PubMed] [Google Scholar]
- [7].Dunys J, Valverde A, Checler F. Are N- And C-terminally truncated A β species key pathological triggers in Alzheimer’s disease? Journal of Biological Chemistry 2018;293:15419–15428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Jang H, Arce FT, Ramachandran S, Capone R, Azimova R, Kagan BL, et al. Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome. Proceedings of the National Academy of Sciences 2010. 4;107:6538–6543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Scheidt HA, Adler J, Krueger M, Huster D. Fibrils of truncated pyroglutamyl-modified Aβ Peptide exhibit a similar structure as wildtype mature Aβ fibrils. Scientific Reports 2016;6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, et al. Characterization of Aβ11–40/42 peptide deposition in Alzheimer’s disease and young Down’s syndrome brains: implication of N-terminally truncated Aβ species in the pathogenesis of Alzheimer’s disease. Acta neuropathologica 2006;112:163–174. [DOI] [PubMed] [Google Scholar]
- [11].Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, et al. Mass spectrometric characterization of brain amyloid β isoform signatures in familial and sporadic Alzheimer’s disease. Acta Neuropathologica 2010. 8;120:185–193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Schilling S, Lauber T, Schaupp M, Manhart S, Scheel E, Böhm G, et al. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 2006;45(41):12393–12399. [DOI] [PubMed] [Google Scholar]
- [13].Bridel C, Hoffmann T, Meyer A, Durieux S, Koel-Simmelink MA, Orth M, et al. Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients. Alzheimer’s Research and Therapy 2017;9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Cynis H, Scheel E, Saido TC, Schilling S, Demuth HU. Amyloidogenic processing of amyloid precursor protein: Evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-β. Biochemistry 2008;47. [DOI] [PubMed] [Google Scholar]
- [15].Jawhar S, Wirths O, Bayer TA. Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease. Journal of Biological Chemistry 2011. 11;286:38825–38832. 10.1074/jbc.R111.288308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Harigaya Y, Saido TC, Eckman CB, Prada CM, Shoji M, Younkin SG. Amyloid β protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer’s disease brain. Biochemical and Biophysical Research Communications 2000;276:422–427. [DOI] [PubMed] [Google Scholar]
- [17].He W, Barrow CJ. The Aβ 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater β-sheet forming and aggregation propensities in vitro than full-length Aβ. Biochemistry 1999;38. [DOI] [PubMed] [Google Scholar]
- [18].Moro ML, Phillips AS, Gaimster K, Paul C, Mudher A, Nicoll JAR, et al. Pyroglutamate and Isoaspartate modified Amyloid-β in ageing and Alzheimer’s disease. Acta Neuropathologica Communications 2018;6:3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Lemkul JA, Bevan DR. The Role of Molecular Simulations in the Development of Inhibitors of Amyloid β-Peptide Aggregation for the Treatment of Alzheimer’s Disease. ACS Chemical Neuroscience 2012;3(11):845–856. 10.1021/cn300091a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Strodel B Amyloid aggregation simulations: challenges, advances and perspectives. Current Opinion in Structural Biology 2021;67:145–152. https://www.sciencedirect.com/science/article/pii/S0959440X20301871. [DOI] [PubMed] [Google Scholar]
- [21].Sgourakis NG, Merced-Serrano M, Boutsidis C, Drineas P, Du Z, Wang C, et al. Atomic-Level Characterization of the Ensemble of the Aβ(1–42) Monomer in Water Using Unbiased Molecular Dynamics Simulations and Spectral Algorithms. Journal of Molecular Biology 2011. 1;405:570–583. https://linkinghub.elsevier.com/retrieve/pii/S002228361001123X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Lincoff J, Sasmal S, Head-Gordon T. The combined force field-sampling problem in simulations of disordered amyloid-β peptides. The Journal of Chemical Physics 2019. 3;150:104108. 10.1063/1.5078615 http://aip.scitation.org/doi/10.1063/1.5078615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Gillman AL, Jang H, Lee J, Ramachandran S, Kagan BL, Nussinov R, et al. Activity and architecture of pyroglutamate-modified amyloid-β (AβpE3–42) pores. Journal of Physical Chemistry B 2014;118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Lemkul JA, Huang J, Roux B, MacKerell AD Jr. An Empirical Polarizable Force Field Based on the Classical Drude Oscillator Model: Development History and Recent Applications. Chemical Reviews 2016;116:4983–5013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Lin FY, Huang J, Pandey P, Rupakheti C, Li J, Roux B, et al. Further Optimization and Validation of the Classical Drude Polarizable Protein Force Field. Journal of Chemical Theory and Computation 2020;16:3221–3239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].Davidson DS, Kraus JA, Montgomery JM, Lemkul JA. Effects of Familial Alzheimer’s Disease Mutations on the Folding Free Energy and Dipole–Dipole Interactions of the Amyloid β-Peptide. The Journal of Physical Chemistry B 2022;126(39):7552–7566. 10.1021/acs.jpcb.2c03520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, et al. , Gaussian09 Revision E.01; 2009. Gaussian Inc. Wallingford CT: 2009. [Google Scholar]
- [28].Smith DGA, Burns LA, Simmonett AC, Parrish RM, Schieber MC, Galvelis R, et al. Psi4 1.4: Open-source software for high-throughput quantum chemistry. The Journal of Chemical Physics 2020. 5;152:184108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Brooks BR, Brooks III CL, MacKerell AD Jr, Nilsson L, Petrella RJ, Roux B, et al. CHARMM: The biomolecular simulation program. Journal of Computational Chemistry 2009;30(10):1545–1614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Kirkpatrick S, Gelatt CD, Vecchi MP. Optimization by Simulated Annealing. Science 1983. 5;220:671–680. [DOI] [PubMed] [Google Scholar]
- [31].Ransil BJ. Studies in Molecular Structure. IV. Potential Curve for the Interaction of Two Helium Atoms in Single-Configuration LCAO MO SCF Approximation. The Journal of Chemical Physics 1961. 6;34:2109–2118. [Google Scholar]
- [32].Boys SF, Bernardi F. The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors. Molecular Physics 1970. 10;19:553–566. [Google Scholar]
- [33].Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, Groot BLD, et al. CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nature Methods 2016;14:71–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [34].Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics 1983;79:926–935. [Google Scholar]
- [35].Neria E, Fischer S, Karplus M. Simulation of activation free energies in molecular systems. Journal of Chemical Physics 1996;105:1902–1921. [Google Scholar]
- [36].Durell SR, Brooks BR, Ben-naim A. Solvent-Induced Forces between Two Hydrophilic Groups. Journal of Physical Chemistry 1994;98:2198–2202. [Google Scholar]
- [37].Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, et al. Scalable molecular dynamics with NAMD. J Comput Chem 2005;26(16):1781–1802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [38].Martyna GJ, Tobias DJ, Klein ML. Constant pressure molecular dynamics algorithms. The Journal of Chemical Physics 1994;101:4177–4189. [Google Scholar]
- [39].Feller SE, Zhang Y, Pastor RW, Brooks BR. Constant pressure molecular dynamics simulation: The Langevin piston method. The Journal of Chemical Physics 1995;103:4613–4621. [Google Scholar]
- [40].Darden T, York D, Pedersen L. Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. The Journal of Chemical Physics 1993;98:10089–10092. [Google Scholar]
- [41].Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. The Journal of Chemical Physics 1995;103:8577–8593. [Google Scholar]
- [42].Ryckaert JP, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of N-alkanes. Journal of Computational Physics 1977;23:327–341. [Google Scholar]
- [43].Lamoureux G, Harder E, Vorobyov IV, Roux B, MacKerell AD Jr. A polarizable model of water for molecular dynamics simulations of biomolecules. Chemical Physics Letters 2006;418:245–249. [Google Scholar]
- [44].Jiang W, Hardy DJ, Phillips JC, MacKerell AD Jr, Schulten K, Roux B. High-performance scalable molecular dynamics simulations of a polarizable force field based on classical Drude oscillators in NAMD. Journal of Physical Chemistry Letters 2011;2:87–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [45].Lamoureux G, Roux B. Modeling induced polarization with classical Drude oscillators: Theory and molecular dynamics simulation algorithm. Journal of Chemical Physics 2003;119:3025–3039. [Google Scholar]
- [46].Chowdhary J, Harder E, Lopes PEM, Huang L, MacKerell AD Jr, Roux B. A polarizable force field of dipalmitoylphos-phatidylcholine based on the classical Drude model for molecular dynamics simulations of lipids. Journal of Physical Chemistry B 2013;117:9142–9160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [47].Eastman P, Swails J, Chodera JD, McGibbon RT, Zhao Y, Beauchamp KA, et al. OpenMM 7: Rapid development of high performance algorithms for molecular dynamics. PLOS Computational Biology 2017. 7;13:e1005659. 10.1371/journal.pcbi.1005659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [48].Huang J, Lemkul JA, Eastman PK, MacKerell AD Jr. Molecular dynamics simulations using the drude polarizable force field on GPUs with OpenMM: Implementation, validation, and benchmarks. Journal of Computational Chemistry 2018. 8;39:1682–1689. 10.1002/jcc.25339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [49].Lemkul JA, Huang J, MacKerell AD Jr. Induced Dipole-Dipole Interactions Influence the Unfolding Pathways of WildType and Mutant Amyloid β-Peptides. The Journal of Physical Chemistry B 2015. 12;119:15574–15582. 10.1021/acs.jpcb.5b09978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [50].Carpenter GA, Grossberg S. ART 2: self-organization of stable category recognition codes for analog input patterns. Appl Opt 1987. Dec;26(23):4919–4930. https://opg.optica.org/ao/abstract.cfm?URI=ao-26-23-4919. [DOI] [PubMed] [Google Scholar]
- [51].Pao YH. Adaptive Pattern Recognition and Neural Networks. USA: Addison-Wesley Longman Publishing Co., Inc.; 1989. [Google Scholar]
- [52].Karpen ME, Tobias DJ, Brooks CLI. Statistical clustering techniques for the analysis of long molecular dynamics trajectories: analysis of 2.2-ns trajectories of YPGDV. Biochemistry 1993;32(2):412–420. 10.1021/bi00053a005. [DOI] [PubMed] [Google Scholar]
- [53].Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 2015;1–2:19–25. [Google Scholar]
- [54].Broersen K, Rousseau F, Schymkowitz J. The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer’s disease: oligomer size or conformation? Alzheimer’s Research & Therapy 2010;2:12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [55].Kirkitadze MD, Condron MM, Teplow DB. Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis. Journal of Molecular Biology 2001. 10;312:1103–1119. [DOI] [PubMed] [Google Scholar]
- [56].Nath S, Buell AK, Barz B. Pyroglutamate-modified amyloid β(3–42) monomer has more β-sheet content than the amyloid β(1–42) monomer. Physical Chemistry Chemical Physics 2023;25:16483–16491. [DOI] [PubMed] [Google Scholar]
- [57].Huang J, MacKerell AD Jr. Induction of peptide bond dipoles drives cooperative helix formation in the (AAQAA)3 peptide. Biophysical Journal 2014;107:991–997. 10.1016/j.bpj.2014.06.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [58].Ahmed MC, Papaleo E, Lindorff-Larsen K. How well do force fields capture the strength of salt bridges in proteins? PeerJ 2018;6:e4967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [59].Dobson CM. Protein-misfolding diseases: Getting out of shape. Nature 2002. 8;418:729–730. [DOI] [PubMed] [Google Scholar]
- [60].Wada A The α-helix as an electric macro-dipole. Adv Biophys 1976;p. 1–63. [PubMed] [Google Scholar]
- [61].Guo H, Karplus M. Solvent Influence on the Stability of the Peptide Hydrogen Bond: A Supramolecular Cooperative Effect. The Journal of Physical Chemistry 1994. 07;98(29):7104–7105. [Google Scholar]
- [62].Ngo VA, Fanning JK, Noskov SY. Comparative Analysis of Protein Hydration from MD simulations with Additive and Polarizable Force Fields. Advanced Theory and Simulations 2019;2(2):1800106. 10.1002/adts.201800106. [DOI] [Google Scholar]
- [63].Lemkul JA, MacKerell AD Jr. Polarizable Force Field for DNA Based on the Classical Drude Oscillator: I. Refinement Using Quantum Mechanical Base Stacking and Conformational Energetics. Journal of Chemical Theory and Computation 2017;13. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The input files (coordinates, topologies, and associated force field parameter files) are available via the Open Science Framework at https://osf.io/mqcfd/. Examples of CHARMM, NAMD, and OpenMM input scripts are available at https://github.com/jalemkul/mimb2020.
